KR
57
-6
FRT
46
3
JPM
59
-3
NDAQ
50
-6
FAST
46
-3
MU
42
7
EFX
60
11
STZ
54
2
CMS
57
3
AXP
69
2
IPG
49
2
JWN
61
5
MCHP
43
6
AZO
62
4
QCOM
55
2
DRI
48
3
MRK
33
3
EW
53
-2
CSX
44
-2
PVH
60
2
KR
57
-6
FRT
46
3
JPM
59
-3
NDAQ
50
-6
FAST
46
-3
MU
42
7
EFX
60
11
STZ
54
2
CMS
57
3
AXP
69
2
IPG
49
2
JWN
61
5
MCHP
43
6
AZO
62
4
QCOM
55
2
DRI
48
3
MRK
33
3
EW
53
-2
CSX
44
-2
PVH
60
2
Financhill
Back

Kyorin Pharmaceutical 10K Form

Sell
50

KYRNF
Kyorin Pharmaceutical

Last Price:
10.00
Seasonality Move:
0%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KYRNF News And Ratings

See the #1 stock for the next 7 days that we like better than KYRNF

KYRNF Financial Statistics

Sales & Book Value

Annual Sales: $828.34M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $15.04
Price / Book: 0.63

Profitability

EPS (TTM): 0.64920
Net Income (TTM): $37.28M
Gross Margin: $356.25M
Return on Equity: 4.14%
Return on Assets: 3.1%

Kyorin Pharmaceutical Earnings Forecast

Key Kyorin Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 20 years for KYRNF is 43.01%.
  • The Interest Expense is 1.24% of Operating Income.
  • The Net Earning history of KYRNF is 4.45% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 10 years.

Kyorin Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: KYRNF
Website: kyorin-pharm.co.jp

Debt

Debt-to-Equity Ratio: 0.16
Current Ratio: 2.62
Quick Ratio: 1.36

Price-to-Earnings

Trailing P/E Ratio: 15.56
Forward P/E Ratio: 0

KYRNF Technical Analysis vs Fundamental Analysis

Sell
50
Kyorin Pharmaceutical (KYRNF) is a Sell

Is Kyorin Pharmaceutical a Buy or a Sell?